ARTICLE

FindCenter AddIcon

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

By Andrew Jacobs — 2021

Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy. They also induce neuroplasticity, the brain’s ability to change and reorganize thought patterns, enabling people with psychological disorders to find new ways to process anxiety, depression or deeply embedded trauma. “They can help people who have lost the plotline of their lives,” Dr. Doblin said.

Read on www.nytimes.com

FindCenter Post-Image

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

FindCenter AddIcon
FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

FindCenter AddIcon
FindCenter Post-Image

I Took Ketamine for My Depression. Things Got Pretty Weird.

My first encounter with ketamine did not go well.

FindCenter AddIcon
FindCenter Post-Image

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

FindCenter AddIcon
FindCenter Post-Image

Introducing Ayahuasca

Amazonian healing traditions collide with Western medical sensibilities.

FindCenter AddIcon
FindCenter Post-Image

Experimental Treatments Changed the Course of the AIDS Epidemic; We Need the Same Approach to Mental Illness Today | Commentary

Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.

FindCenter AddIcon
FindCenter Post-Image

Ketamine Is Revealing a New Understanding of Depression and the Brain

Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.

FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

FindCenter AddIcon
FindCenter Post-Image

Nasal Spray vs. Iv Ketamine for Depression

The efficacy of two forms of ketamine treatments for depression is compared.

FindCenter AddIcon
FindCenter Post-Image

Rapid Antidepressant Effects of the Psychedelic Ayahuasca Linked to Changes in Inflammatory Biomarkers

The antidepressant effects of the psychedelic brew known as ayahuasca appear to be related to anti-inflammatory activity, according to new research from scientists in Brazil.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research